Vlagen, L C

Artemis Biotechnologies LLC is a research and development company based in Austin, TX, specializing in innovative biotechnological solutions. With a focus on cutting-edge advancements in the field, Artemis Biotechnologies LLC is dedicated to pushing the boundaries of scientific discovery and creating impactful technologies for the future. Generated from their business information

Speragen, Inc. is a biopharmaceutical company based in Austin, TX, specializing in the development of innovative treatments for rare disorders. With a focus on Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD), Speragen aims to provide hope and support to patients and families affected by this often underdiagnosed disorder. Through a partnership with GC Pharma, Speragen is working on the development of an enzyme replacement therapy (ERT) and launching a newborn screening program for early identification of SSADHD patients. GC Pharma, formerly known as Green Cross Corporation, is a global biopharmaceutical company headquartered in Yongin, South Korea. With a strong commitment to quality healthcare solutions, GC Pharma has been a leader in the production of plasma protein therapeutics and vaccines for over 50 years. Through their collaboration with Speragen, GC Pharma brings their expertise in ERT development and manufacturing to advance the treatment options for SSADHD, addressing the unmet needs of patients worldwide.Generated from the website

Veracyte is a leading molecular diagnostics company based in Austin, TX, specializing in providing exceptional cancer care through their high-value insights and tests. Their comprehensive portfolio includes genomic sequencing classifiers for diseases such as thyroid cancer, prostate cancer, lung cancer, breast cancer, bladder cancer, and interstitial lung disease, among others. Veracyte's tests enable clinicians and patients to make more informed and confident decisions, avoiding unnecessary procedures and speeding up the time to appropriate diagnosis and treatment. With a proven framework and a collaborative approach with clinicians and scientists, Veracyte identifies unmet needs in cancer care and develops high-performance tests to address them. Their rigorous process ensures product performance and utility, building evidence through a broad range of studies. Veracyte aims to make leading diagnostics accessible to patients worldwide, with their centralized CLIA lab-based approach in the US and a growing menu of distributed in vitro diagnostic (IVD) tests to serve global markets.Generated from the website